Vident Advisory’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $483K | Sell |
15,289
-59
| -0.4% | -$1.86K | 0.01% | 1076 |
|
|
2025
Q1 | $509K | Sell |
15,348
-1,078
| -7% | -$35.8K | 0.01% | 1022 |
|
|
2024
Q4 | $565K | Buy |
16,426
+2,493
| +18% | +$85.8K | 0.01% | 880 |
|
|
2024
Q3 | $557K | Sell |
13,933
-7,365
| -35% | -$295K | 0.01% | 870 |
|
|
2024
Q2 | $643K | Buy |
+21,298
| New | +$643K | 0.02% | 772 |
|
|
2024
Q1 | – | Sell |
-6,312
| Closed | -$204K | – | 1361 |
|
|
2023
Q4 | $204K | Sell |
6,312
-5,529
| -47% | -$179K | 0.01% | 1208 |
|
|
2023
Q3 | $388K | Buy |
+11,841
| New | +$388K | 0.01% | 787 |
|